Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Medication Response for Autoimmune Disease

NCT04995783 is registered in ClinicalTrials.gov with Coral Genomics, Inc. as lead sponsor.

NCT NCT04995783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Medication Response for Autoimmune Disease
Lead sponsor
Coral Genomics, Inc.
Phase
Observational
Overall status
Terminated
Start date
September 1, 2020
Completion date
August 1, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, psoriasis, rheumatoid arthritis, ulcerative colitis